Drug intelligence / Profile preview

4′-[methyl-11C]-thiothymidine

Development stage
Preclinical
Lead developer
National Institute of Radiological Sciences
Modality
Small Molecules, Antibody-Radionuclide Conjugates → Antibody Conjugates → Antibody-Based Therapeutics
Administration
Intravenous
01

Overview

4′-[methyl-11C]-thiothymidine (also known as 11C-4DST) is a radiolabeled thymidine analog used as a positron emission tomography (PET) tracer for imaging cellular proliferation. The compound is labeled with carbon-11 at the methyl group and features a sulfur atom replacing the oxygen at the 4' position of thymidine, making it structurally similar to natural thymidine but resistant to degradation by thymidine phosphorylase. After administration, it is incorporated into DNA in proliferating cells, allowing noninvasive visualization and quantification of cell proliferation in vivo. This property makes it particularly useful for imaging tumor growth and aggressiveness in cancers such as non–small cell lung cancer and high-grade gliomas[2][3]. Its uptake reflects activity of S-phase–specific enzymes like thymidine kinase, which are upregulated during DNA synthesis[2].

Other names
methyl-[11C]-4'-thiothymidine[methyl-^11C]thiothymidine
02

Targets

TK2 (Thymidine kinase 2)TK1 (Thymidine kinase 1)

Beyond the preview

Go deeper on 4′-[methyl-11C]-thiothymidine.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on 4′-[methyl-11C]-thiothymidine.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call